Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This letter to the editor compares the efficacy and safety of bimatoprost 0.03% with minoxidil 3% for eyebrow enhancement but does not report any study results.

This letter details a case report on platelet-rich plasma treatment for a patient with treatment-resistant frontal fibrosing alopecia, but it does not provide new clinical results.

This letter discusses potential pathogenetic links among frontal fibrosing alopecia, androgenetic alopecia, and fibrosing alopecia in a pattern distribution and reports no new clinical findings.

This letter discusses the causes of gray hair, noting both genetic factors and potential associations with other conditions or certain medications, but reports no new findings.

This letter describes a case of a 22-year-old woman with ichthyosis serpentina and related symptoms, suggesting it as a variant form of ichthyosis associated with bamboo hair, without necessarily including atopic features.

This letter describes a case where severe pruritus without visible skin disease was a presenting symptom of hyperthyroidism in a 43-year-old woman, highlighting a less common association with the condition.

This letter to the editor shares concerns about possible systemic effects from topical dinitrochlorobenzene therapy in a 25-year-old man treating alopecia areata.

This letter details 11 cases of scalp pseudocyst treated primarily with intralesional triamcinolone, resulting in complete hair regrowth in eight patients and self-resolution in some instances.

This letter to the editor raises concerns about the possibility of cornrowing leading to dermatologic problems such as traction alopecia, paralleling issues seen with other cosmetic fads.

This letter to the editor discusses the use of systemic minoxidil for loose anagen hair syndrome, noting a significant change in hair color, but reports no new study results.

This article is a Letter to the Editor discussing rebound effects associated with JAK inhibitor use in treating alopecia areata and reports no new clinical results.

This letter highlights that levonorgestrel intrauterine devices may lead to fewer systemic side effects, like acne, compared to its oral administration due to lower systemic levels of progestogens.

This letter describes a case where a 43-year-old woman experienced severe itching as the presenting symptom of hyperthyroidism, alongside hair loss and other hyperthyroid features.

This letter discusses the limited adaptation of low dose oral minoxidil for androgenetic alopecia in North America and reports no new clinical results; the authors suggest safety concerns or unclear dosing may be factors.

This article is a letter to the editor discussing positive Jacquet's sign in traction alopecia and provides no new research results.

This letter to the editor discusses an observed case of hair repigmentation linked with etretinate therapy but reports no new research findings.

This letter provides no study results about minoxidil 3% lotion for beard enhancement but instead shares author and affiliation details for the published research.

This letter discusses potential hair loss effects of Hedgehog inhibitors but presents no new clinical findings, urging further exploration of this possible class effect.

This letter to the editor about prostaglandins in androgenetic alopecia in men and women reports no new research findings.

This letter describes cases in which papilledema and other symptoms in young girls were attributed to hypervitaminosis A.

This letter comments on a randomized controlled trial by Shapiro et al that found no significant benefits of platelet-rich plasma compared to placebo for male androgenetic alopecia, highlighting issues with PRP protocol variations.

This letter discusses the high prevalence and limited treatment options for pattern hair loss, noting the associated psychological distress, especially in women, and reports no new clinical findings.

This letter discusses adverse events related to low-dose oral minoxidil for alopecia, highlighting age-related risks and stressing the importance of contraindication awareness with no new clinical results presented.

This letter discusses how severe baldness in men is associated with higher risk of severe COVID-19, and highlights research suggesting antiandrogen medications may improve outcomes.

This letter reported that combining platelet-rich plasma with hair transplants did not show benefits for treating androgenetic alopecia.

This letter to the editor discusses immune checkpoint inhibitor-related alopecia and insights into its pathophysiology using non-invasive diagnostic techniques, but reports no new clinical results.

This letter praises an article on gluteal fat transplantation and concludes that adhering to recommended safety practices could minimize fat embolism risks, making fat grafting a potentially safer option for gluteal augmentation.

This letter reports no new findings and discusses potential concerns regarding 5-alpha reductase inhibitors on lung function, suggesting a reason for discontinuation during the COVID-19 pandemic.

This letter compares automated digital image analysis (TrichoScan) with manual marking of hairs in male patients with androgenetic alopecia but reports no new results.

This letter highlights that the effectiveness of skin self-photography for melanoma detection has not been evaluated, although it could be a cost-effective option for patients without access to professional skin photography.